Pharma Intelligence is part of the Informa Intelligence Division of Informa PLC
This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Get coverage of the latest pharmaceutical business developments, and historical metrics on financing, licensing, partnership, and acquisition.
Our trusted Pharma Intelligence brands
Pink Sheet
15 Jul 2019
Get expert insights into the events driving drug pricing polices around the world. This Article Pack covers drug pricing issues for: The EU - Vital developments for Norway, Denmark, and other EU countries, including the UK The US – Essential drug pricing info from a country where the issue has taken center stage Australia – Developments surrounding drug pricing issues in Australia
Pink Sheet
15 Jul 2019
Get expert insights into the events driving drug pricing polices around the world. This article pack covers drug pricing issues for: The EU - Vital developments for Norway, Denmark, and other EU countries, including the UK The US – Essential drug pricing info from a country where the issue has taken center stage Australia – Developments surrounding drug pricing issues in Australia
Topic Policy and regulation Drug development landscape Deal trends
Datamonitor Healthcare
15 Jul 2019
Our latest whitepaper lists the top selling drugs last year, who developed them and the strategies behind their success. We drew from three of our top products to create our most recent whitepaper, Datamonitor Health Care, Biomedtracker and Pharmaprojects. You can experience them all for yourself.
Topic Drug review Strategy Deal trends
In Vivo
15 Jul 2019
Get exclusive info on the leaders of the Pharma industry.The 2019 Titan of Pharma infographic is a snapshot of the industry’s top leaders and the businesses they oversee.
Topic Company analysis Strategy
Datamonitor Healthcare, Biomedtracker, Pharmapremia
By Hardik Patel 15 Jul 2019
Informa Pharma Intelligence presents an essential, free session during which industry analysts present their data-driven views about what to expect during the third quarter of 2019.
In Vivo
By Ashley Yeo 12 Jul 2019
Medtech’s contribution to health care improvements in Europe over the past 30 years has been a phenomenal journey of success – in patient terms as well as in commercial terms, says MedTech Europe chair Rob ten Hoedt. Local creativity has been able to mine a seam of product innovation that is unmatched anywhere in the world, but the sector is facing massive change and must find ways to cope.
Topic Medtech Digital Health
Generics Bulletin
By Penelope MacRae 12 Jul 2019
The US FDA has slapped Biocon with a dozen observations over three units at its insulin manufacturing facility in Malaysia, but the Indian biotech firm says the problems can be remedied quickly and that US launch plans are on track for its insulin product glargine challenging French drug-maker Sanofi’s multi-billion-dollar Lantus.
Topic FDA Diabetes BioPharmaceutical
Medtech Insight
By Marion Webb 12 Jul 2019
This year, Omron Healthcare launched its new HeartGuide smartwatch and the first FDA-cleared blood pressure monitor with EKG capability. Medtech Insight sat down with Omron's CEO Ranndy Kellogg to learn about upcoming plans.
Topic FDA Digital Health
Medtech Insight
By Shawn M. Schmitt 12 Jul 2019
The US agency's Case for Quality Voluntary Improvement Program – used to measure a device-maker's manufacturing maturity and quality – has surprisingly been used to assess some pharmaceutical facilities. Meanwhile, regulators from other countries have been reaching out informally to the FDA to learn more about CFQ VIP.
Topic FDA Policy and regulation
Scrip
By Ian Schofield 12 Jul 2019
The pharmaceutical industry has come under attack by a UK parliament committee for failing to make medicinal cannabis products available for clinical trials, saying that a "robust research base" is needed on which to base future treatment decisions.
Topic Clinical trials Drug approval
HBW Insight
10 Jul 2019
Cannabidiol (CBD) is being looked at more and more by health beauty and wellness companies for new OTC drugs, cosmetics and supplements. It is highly controversial because while CBD has many natural benefits for treating a variety of symptoms and conditions, it is the active ingredient in cannabis which comes from the hemp plant.
Topic Drug review Drug approval
HBW Insight
By David Ridley 05 Jul 2019
The UK's cannabidiol market, which according to the Cannabis Trades Association is the largest in Europe, awaits clarification on the legal status of CBD-containing food supplements. Meanwhile, major retailers like Walgreen Boots Alliance are stepping into the space with branded products.
Pink Sheet
By Francesca Bruce 05 Jul 2019
Latin American joint price negotiations have proved successful and other countries are taking note.
Medtech Insight
By Bernard Murphy 05 Jul 2019
Enhancing trust in medical devices and medtech companies is the aim of a new agreement between the Spanish medtech industry and an organization specializing in helping businesses meet and maintain high legal and ethical standards.
Medtech Insight
By Amanda Maxwell 05 Jul 2019
The European Commission came under a great deal of pressure in June to deliver the fundamental structures and documents needed for implementing the EU’s new medtech regulations. It has hit the ground running so far this month.
Topic Policy and regulation
Medtech Insight
16 Jul 2019
Pink Sheet
16 Jul 2019
Scrip
16 Jul 2019
Medtech Insight
16 Jul 2019
Medtech Insight
16 Jul 2019
Medtech Insight
16 Jul 2019
Pink Sheet
16 Jul 2019
Medtech Insight
16 Jul 2019
Pink Sheet
16 Jul 2019
Pink Sheet
16 Jul 2019
Medtech Insight
16 Jul 2019
Scrip
16 Jul 2019
Scrip
16 Jul 2019
Medtech Insight
16 Jul 2019
Medtech Insight
16 Jul 2019
Trialtrove is the go-to resource for clinical trial research. Easily track your competitors' clinical R&D activity with expert insights and continually monitored trials.
Key benefits:
Datamonitor Healthcare's expert coverage of key diseases, companies, drugs and market trends makes it the go-to product for pharmaceutical and biotechnology companies to support the development and validation of their strategic plans and commercial decisions.
Key benefits:
Key benefits:
09 Aug 2019 , 08:00 GMT
London , UK
Industry conference
24 Aug 2019 , 08:00 CST
Austria
Industry conference
23 Sep 2019
USA
Awards
Request a live demo
Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.
Request live demo now:
How can we help you?
Our team is always happy to hear from you. Please call us at:
Pharma Report Store
Have an immediate and specific information need?
Browse and buy from 1000s of analysis and research reports now:
Keep up to date